ArticlePharmaceutical research2014

Pharmacokinetics and efficacy of the spleen tyrosine kinase inhibitor r406 after ocular delivery for retinoblastoma.

Eleanor M Pritchard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.